Market Cap 19.38M
Revenue (ttm) 0.00
Net Income (ttm) -15.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 371,200
Avg Vol 177,604
Day's Range N/A - N/A
Shares Out 5.41M
Stochastic %K 36%
Beta -0.75
Analysts Strong Sell
Price Target $30.40

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
ZacksResearch
ZacksResearch Oct. 24 at 8:50 PM
$CING gets a big spotlight at AACAP šŸŽÆ Cingulate’s lead ADHD candidate, CTx-1301, was selected for a podium presentation at the American Academy of Child and Adolescent Psychiatry Annual Meeting — a strong validation of its Phase 3 data and scientific rigor. šŸ’Š The once-daily, extended-release design aims to simplify ADHD treatment and address key limitations of current stimulant therapies. See what Wall Street expects next šŸ‘‰ https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-17687&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_17687
0 Ā· Reply
lordofthesox
lordofthesox Oct. 24 at 7:03 PM
$CING I expect a lot of this up and down but no real movement until we get a real catalyst.
1 Ā· Reply
PhiloftheFuture
PhiloftheFuture Oct. 24 at 6:15 PM
Loaded up on my highest conviction holdings over the past week. $CRSP $RDW $CADL $CING
0 Ā· Reply
Itinerant
Itinerant Oct. 24 at 2:23 PM
$CING This company is seriously under valued. I have established my initial long position. JMO
1 Ā· Reply
fullobullz
fullobullz Oct. 24 at 1:15 PM
$CING Ctx1301 presentation today by Dr Ann
1 Ā· Reply
Hrk024
Hrk024 Oct. 24 at 1:10 AM
$CING šŸ§ØšŸ§ØšŸ§ØšŸš€šŸš€šŸš€šŸš€šŸš€šŸ˜ŽšŸ‘Œ
0 Ā· Reply
ru8fru
ru8fru Oct. 23 at 9:25 PM
$CING added
0 Ā· Reply
unearthedmosquito
unearthedmosquito Oct. 23 at 9:23 PM
$CING Adding 3.70s, ahead of CTx-1301 data
0 Ā· Reply
pitkineagle
pitkineagle Oct. 23 at 9:10 PM
$CING Dr. Ann šŸ’ŖšŸ»šŸ’ŖšŸ»šŸ’ŖšŸ»
0 Ā· Reply
STKH
STKH Oct. 23 at 8:53 PM
$CING Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting
0 Ā· Reply
Latest News on CING
Cingulate Provides Management Team Update

Aug 15, 2025, 9:00 AM EDT - 2 months ago

Cingulate Provides Management Team Update


Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 1 year ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 1 year ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 1 year ago

Cingulate Announces Adjournment of Special Meeting


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 1 year ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 1 year ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 1 year ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Cingulate to Host CNS Key Opinion Leader Panel in New York City

Oct 17, 2023, 2:22 PM EDT - 2 years ago

Cingulate to Host CNS Key Opinion Leader Panel in New York City


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 2 years ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 2 years ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


Cingulate Announces Closing of $4.0 Million Public Offering

Sep 13, 2023, 4:15 PM EDT - 2 years ago

Cingulate Announces Closing of $4.0 Million Public Offering


Cingulate Announces Pricing of $4.0 Million Public Offering

Sep 11, 2023, 9:22 AM EDT - 2 years ago

Cingulate Announces Pricing of $4.0 Million Public Offering


Cingulate to Present at 13th Annual LD Micro Invitational

May 25, 2023, 3:55 PM EDT - 2 years ago

Cingulate to Present at 13th Annual LD Micro Invitational


ZacksResearch
ZacksResearch Oct. 24 at 8:50 PM
$CING gets a big spotlight at AACAP šŸŽÆ Cingulate’s lead ADHD candidate, CTx-1301, was selected for a podium presentation at the American Academy of Child and Adolescent Psychiatry Annual Meeting — a strong validation of its Phase 3 data and scientific rigor. šŸ’Š The once-daily, extended-release design aims to simplify ADHD treatment and address key limitations of current stimulant therapies. See what Wall Street expects next šŸ‘‰ https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-17687&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_17687
0 Ā· Reply
lordofthesox
lordofthesox Oct. 24 at 7:03 PM
$CING I expect a lot of this up and down but no real movement until we get a real catalyst.
1 Ā· Reply
PhiloftheFuture
PhiloftheFuture Oct. 24 at 6:15 PM
Loaded up on my highest conviction holdings over the past week. $CRSP $RDW $CADL $CING
0 Ā· Reply
Itinerant
Itinerant Oct. 24 at 2:23 PM
$CING This company is seriously under valued. I have established my initial long position. JMO
1 Ā· Reply
fullobullz
fullobullz Oct. 24 at 1:15 PM
$CING Ctx1301 presentation today by Dr Ann
1 Ā· Reply
Hrk024
Hrk024 Oct. 24 at 1:10 AM
$CING šŸ§ØšŸ§ØšŸ§ØšŸš€šŸš€šŸš€šŸš€šŸš€šŸ˜ŽšŸ‘Œ
0 Ā· Reply
ru8fru
ru8fru Oct. 23 at 9:25 PM
$CING added
0 Ā· Reply
unearthedmosquito
unearthedmosquito Oct. 23 at 9:23 PM
$CING Adding 3.70s, ahead of CTx-1301 data
0 Ā· Reply
pitkineagle
pitkineagle Oct. 23 at 9:10 PM
$CING Dr. Ann šŸ’ŖšŸ»šŸ’ŖšŸ»šŸ’ŖšŸ»
0 Ā· Reply
STKH
STKH Oct. 23 at 8:53 PM
$CING Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting
0 Ā· Reply
TA_Kongen
TA_Kongen Oct. 23 at 8:47 PM
$CING There is no way this is NOT gonna end up a dud.
3 Ā· Reply
Mprifold
Mprifold Oct. 23 at 4:46 PM
$CING like I said 3.50 incoming. Wait until after earnings to jump in around 3.30-3.00 range.
1 Ā· Reply
aak12345
aak12345 Oct. 23 at 3:35 PM
$CING started a position here
0 Ā· Reply
Irakli2508
Irakli2508 Oct. 23 at 3:23 PM
$CING I added 1200 shares today.
0 Ā· Reply
Irakli2508
Irakli2508 Oct. 23 at 2:54 PM
0 Ā· Reply
SamMusaX
SamMusaX Oct. 23 at 12:58 AM
$CING Each week we get closer to Office Action. In the 16 week window we are entering week 4. There are only 12 weeks left before we see office action at a the latest! Based on historical averages for pharmaceutical filings, the First Office Action is anticipated between Oct 2025 - Jan 2026.
2 Ā· Reply
SamMusaX
SamMusaX Oct. 23 at 12:57 AM
$CING The Wednesday Weekly USA patent update. Change or no change, every Wednesday, will be posting it: Here’s the updated status for Application US 18/661,378 (Tripulse Release Stimulant Formulations), as of October 22, 2025: ________________________________________ Application US18/661,378 (Tripulse Release Stimulant Formulations) • 2024-05-10 – Application filed by Cingulate Therapeutics LLC • 2024-05-10 – Priority date established (same day as filing) • 2024-11-11 – Assignment recorded to Cingulate Therapeutics LLC (Reel/Frame 069201/0426) • 2025-02-13 – Publication of application as US 2025/0049722 A1 • 2025-10-22 (today) – Status: Pending (no Office Action issued yet; still early in prosecution) ________________________________________ Notes • The application remains in the early USPTO examination phase. • No new docket updates, examiner assignment, or correspondence have appeared since publication. • the First Office Action is still projected for late-2025 to Q1 2026.
0 Ā· Reply
StockGuru320
StockGuru320 Oct. 22 at 12:13 PM
$BBAI I loaded the fucking boat this morning! See short interest! This is gonna take off like a rocket IMO! Loaded $BBAI and $CING heavily.
0 Ā· Reply
StockGuru320
StockGuru320 Oct. 21 at 5:51 PM
$CING @Ro_Patel
1 Ā· Reply
StockGuru320
StockGuru320 Oct. 21 at 5:50 PM
$CING The myth, the man, the legend… AKA the KING of ADHD LFG…this team is stacked.
0 Ā· Reply
StockGuru320
StockGuru320 Oct. 21 at 1:56 PM
$CING buying more!
0 Ā· Reply
activehybrid
activehybrid Oct. 20 at 8:02 PM
$CING updated presentation is available in http://Cingulate.com $200 million is targeted
0 Ā· Reply